Selkäydinnestetoimitus

Selkäydinnestetoimitus, also known as intrathecal drug delivery, is a method of administering medication directly into the cerebrospinal fluid (CSF) that surrounds the spinal cord. This allows for a lower dose of medication to reach the central nervous system, potentially reducing systemic side effects compared to oral or intravenous administration. The delivery system typically consists of a surgically implanted pump and a catheter. The pump, often placed under the skin of the abdomen or back, stores the medication and is programmed to release it at a specific rate. The catheter is then tunneled from the pump to the intrathecal space, usually in the lumbar or thoracic region of the spine.

This method is commonly used for managing chronic pain, particularly when other treatments have been ineffective. It can also be used for spasticity management in conditions like multiple sclerosis or cerebral palsy, and in some cases for chemotherapy delivery to treat certain cancers that have spread to the central nervous system. The decision to use intrathecal drug delivery is made after careful evaluation of the patient's condition, the potential benefits, and the risks involved. While generally safe, potential complications can include infection, catheter displacement, or pump malfunction. Regular monitoring and adjustments by a healthcare professional are essential for effective and safe treatment.